Efficacy and Safety of Sublingual Fentanyl Tablets for the Management of Breakthrough Pain in Patients with Chronic Musculoskeletal Pain with Neuropathic Component: Multicenter Prospective Study-Reference-Cited by-同舟云学术

Efficacy and Safety of Sublingual Fentanyl Tablets for the Management of Breakthrough Pain in Patients with Chronic Musculoskeletal Pain with Neuropathic Component: Multicenter Prospective Study

Published:2015-02-06 Issue:3 Volume:35 Page:169-177
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Cánovas-Martínez Luz,Carceller-Ruiz José J.,Díaz-Parada Pilar,Illodo-Miramontes Gustavo,Freire-Vila Enrique,De la Iglesia-López Aurora,Iglesias Belén García,López-Ulloa Beatriz,Domínguez-Suárez Enrique,Camba-Rodríguez Alberto

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-015-0268-8.pdf

Reference33 articles.

1. Treede RD, Jensen TS, Campbell JN, et al. Redefinition of neuropathic pain and a grading system for clinical use: consensus statement on clinical and research diagnostic criteria. Neurology. 2008;70:1630–5.

2. Argoff CE. The coexistence of neuropathic pain, sleep and psychiatric disorder: a novel treatment approach. Clin J Pain. 2007;23:15–22.

3. McCarberg BH, Billington R. Consequences of neuropathic pain: quality of life issues and associated costs. Am J Managed Care. 2006;12:S263–8.

4. Foley KM. Opioids and chronic neuropathic pain. N Engl J Med. 2003;348:1279–81.

5. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–30.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Administración sublingual y bucal de fármacos en situaciones de urgencia y emergencia vital;Medicina Clínica;2024-07

2. Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness;Breathe;2019-09

3. Sublingual Fentanyl Tablets for Relief of Breakthrough Pain in Cancer Patients and Association with Quality-of-Life Outcomes;Clinical Drug Investigation;2015-10-27